Exploring Preeclampsia: A Comprehensive Overview

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Cardiovascular Physiology

Background:

• Preeclampsia is a significant pregnancy complication characterized by hypertension and proteinuria after 20 weeks gestation.
• Its complex pathology involves endothelial dysfunction, platelet issues, and an imbalance in angiogenic factors.
• Current diagnostic methods include blood pressure monitoring, proteinuria assessment, lab tests, and imaging for organ damage.

Purpose of the Study:

• To review the multifaceted nature of preeclampsia, focusing on its pathology, diagnosis, and management.
• To highlight the critical role of biomarkers, specifically the sFlt-1/PlGF ratio, in early detection and risk stratification.
• To provide a comprehensive resource for clinicians on current knowledge and practical approaches to preeclampsia management.

Main Methods:

• Literature review synthesizing current research on preeclampsia.
• Analysis of diagnostic criteria and laboratory/imaging techniques.
• Evaluation of biomarker roles (sFlt-1, PlGF) in disease prediction and stratification.
• Review of management strategies including antihypertensives, fetal monitoring, and delivery.

Main Results:

• An imbalance in angiogenic factors, particularly the sFlt-1/PlGF ratio, is key to diagnosing and predicting preeclampsia.
• Elevated sFlt-1 and reduced PlGF in high-risk pregnancies correlate with increased clinical severity and adverse maternal/fetal outcomes.
• Management involves antihypertensives, fetal surveillance, and timely delivery based on disease severity.

Conclusions:

• Preeclampsia remains a significant challenge in pregnancy, requiring a multidisciplinary approach.
• Biomarkers like sFlt-1 and PlGF are crucial for improving diagnostic accuracy and risk assessment.
• Continued research into predictive biomarkers and preventative measures is essential for maternal and fetal well-being.